siRNA therapy reduces triglycerides in patients along with rare problem

.STUDY EMPHASIZE.19 September 2024.

Plozasiran minimized triglyceride degrees by 80% and decreased the threat of pancreatitis in people along with relentless chylomicronemia, along with or without a genetic prognosis.